Jean‐Pierre Vannier

Author

Jean‐Pierre Vannier

Also Known As

Felipe Suarez, François Tron, JEAN-PIERRE VANNIER, Jean-Pierre Vannier, Jean‐Pierre Vannier, Vannier, Jean-Pierre, Yves Perel, jean-Pierre Vannier

127

Publications

4.3K

Citations

H-Index

116

Concepts

All Affiliations

Université de Rouen Normandie Inserm Hôpital Charles-Nicolle Centre National de la Recherche Scientifique Hôpital Saint-Louis

About

Jean‐Pierre Vannier is an author at Université de Rouen Normandie specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	33	1.8K
2	Biomedical Engineering	8	8	365
3	Engineering	7	7	303
4	Health Sciences	4	4	100
5	Public Health	2	2	40

Jean‐Pierre Vannier

Publications

Citations

H-Index

Page 1

	Year	Citations
Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease Françoise Bernaudin, Gèrard Socié, Mathieu Kuentz, Blood	2007	494
Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies Alain Fischer, Johan Provot, Jean-Philippe Jaı̈s, Journal of Allergy and Clinical Immunology Primary ImmunodeficiencyRheumatologyInflammationAutoimmune DiseaseAutoantibody Production	2017	304
SDF-1 Activity on Microvascular Endothelial Cells F. Mirshahi, Jérôme Pourtau, Hong Li, Thrombosis Research InflammationAngiogenesisCell SignalingEndothelial DysfunctionVascular Biology	2000	235
Expression of Concern: Inhibition of endothelial cell migration by cerivastatin, an HMG‐CoA reductase inhibitor: contribution to its anti‐angiogenic effect Loı̈c Vincent, Wenming Chen, Hong Li, FEBS Letters	2001	205
Transitional B cells in humans: Characterization and insight from B lymphocyte reconstitution after hematopoietic stem cell transplantation Aude Marie‐Cardine, Florence Divay, Ingrid Dutot, Clinical Immunology Cell TherapyTransplantationMarrow TransplantationLymphocyte DevelopmentStem Cell Transplantation	2008	143
Oncostatin M Induces Angiogenesis In Vitro and In Vivo Marc Vasse, Jérôme Pourtau, Véronique Trochon, Arteriosclerosis Thrombosis and Vascular Biology	1999	135
Cerivastatin, an Inhibitor of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase, Inhibits Endothelial Cell Proliferation Induced by Angiogenic Factors In Vitro and Angiogenesis in In Vivo Models Claudine Soria, F. Mirshahi, Paule Opolon, Arteriosclerosis Thrombosis and Vascular Biology	2002	128
Long-term event-free survival, chimerism and fertility outcomes in 234 patients with sickle-cell anemia younger than 30 years after myeloablative conditioning and matched-sibling transplantation in France Françoise Bernaudin, Jean‐Hugues Dalle, Dominique Bories, Haematologica	2019	125
Molecular mechanism of the anti-cancer activity of cerivastatin, an inhibitor of HMG-CoA reductase, on aggressive human breast cancer cells Christophe Denoyelle, Patricia Albanese, Georges Uzan, Cellular Signalling Breast OncologyHmg-coa ReductaseMedicineMolecular MechanismCell Death	2003	122
Rac3 induces a molecular pathway triggering breast cancer cell aggressiveness: differences in MDA-MB-231 and MCF-7 breast cancer cell lines Caroline Gest, Ulrich Joimel, Limin Huang, BMC Cancer	2013	116

Page 1